RxDoctor Payments Data

Julienne Calamlam, PA

Physician Assistant · Austin, TXNPI 1669171690

Payments from drug & device makers

$699in general payments, 2019–2025

Across 14 payments — averaging $49.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exeltis, USA Inc.$325
  • Astellas Pharma US Inc$180
  • Organon$64
  • AbbVie$29
  • Ascend Therapeutics US, LLC$28
  • Hologic Sales And Service, LLC$23
  • plus $50 from 3 others

What the payments were for

  • Food & beverage$699100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Exeltis, USA Inc.3$325
Astellas Pharma US Inc3$180
Organon1$64
AbbVie1$29
Ascend Therapeutics US, LLC2$28
Hologic Sales And Service, LLC1$23
Avion Pharmaceuticals1$23
Pfizer1$17
Millicent US Inc1$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$699 in reported general payments places this provider in the 55th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$6,881
Medicare patients
82
Services billed
114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol67$5,504
ProgesteroneProgesterone, Micronized97$3,231
Estradiol (Twice Weekly)Estradiol26$1,720
LyllanaEstradiol16$1,387
DottiEstradiol16$980
Levothyroxine Sodium14$790

Paid to pharmacies, not to this prescriber.

Other physician assistant in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →